title: An analysis of fluid loss during transcervical resection of submucous myomas.
abstract: OBJECTIVE
  To determine the contribution of several variables to fluid loss during transcervical resection of submucous myomas.
  
  
  METHODS
  An observational study using multiple linear regression analyses.
  
  
  METHODS
  A university-affiliated training hospital and a university department of clinical epidemiology and biostatistics.
  
  
  METHODS
  Patients with submucous myomas.
  
  
  METHODS
  Transcervical resection of submucous myomas and monitoring of fluid loss.
  
  
  METHODS
  Patient age, uterine enlargement, treatment with GnRH analogues or 8-ornithine-vasopressin, type of anesthesia, number of myomas, intramural extension of the myoma (type of myoma), and operating time were tested as variables.
  
  
  RESULTS
  Only intramural extension of the myoma and operating time were obviously related to fluid loss. For the other variables, such a relation was weak at best. The relation between fluid loss and operating time was not modified by any of the other variables.
  
  
  CONCLUSIONS
  Because fluid loss is an important limiting factor in the transcervical resection of submucous myomas, special attention should be paid to reduction of the operating time and preoperative assessment of the intramural extension of the myoma to guide appropriate patient selection.
authors.affiliation: Department of Obstetrics and Gynecology, Spaarne Hospital, Haarlem, The Netherlands.
authors.forename: M H
authors.initials: MH
authors.lastname: Emanuel
authors.forename: A
authors.initials: A
authors.lastname: Hart
authors.forename: K
authors.initials: K
authors.lastname: Wamsteker
authors.forename: F
authors.initials: F
authors.lastname: Lammes
mesh_terms: D000328:Adult; D002584:Cervix Uteri; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives / Q000627:therapeutic use; D006801:Humans; D007431:Intraoperative Complications; D007889:Leiomyoma / Q000601:surgery*; D008875:Middle Aged; D009951:Ornipressin / Q000627:therapeutic use; D012044:Regression Analysis; D012307:Risk Factors; D013997:Time Factors; D014594:Uterine Neoplasms / Q000601:surgery*; D014883:Water-Electrolyte Imbalance / Q000209:etiology*
chemical_list: D009951:Ornipressin; D007987:Gonadotropin-Releasing Hormone